JP2005535670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005535670A5 JP2005535670A5 JP2004520655A JP2004520655A JP2005535670A5 JP 2005535670 A5 JP2005535670 A5 JP 2005535670A5 JP 2004520655 A JP2004520655 A JP 2004520655A JP 2004520655 A JP2004520655 A JP 2004520655A JP 2005535670 A5 JP2005535670 A5 JP 2005535670A5
- Authority
- JP
- Japan
- Prior art keywords
- function
- pharmacologically active
- platelet aggregation
- modified amino
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013543 active substance Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39689802P | 2002-07-17 | 2002-07-17 | |
| PCT/EP2003/007739 WO2004006907A1 (en) | 2002-07-17 | 2003-07-16 | Modified amino acid for the inhibition of platelet aggregation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005535670A JP2005535670A (ja) | 2005-11-24 |
| JP2005535670A5 true JP2005535670A5 (https=) | 2006-08-24 |
| JP4541884B2 JP4541884B2 (ja) | 2010-09-08 |
Family
ID=30116066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520655A Expired - Fee Related JP4541884B2 (ja) | 2002-07-17 | 2003-07-16 | 血小板凝集の阻害のための修飾アミノ酸 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20060106110A1 (https=) |
| EP (1) | EP1556027B1 (https=) |
| JP (1) | JP4541884B2 (https=) |
| CN (1) | CN1668290B (https=) |
| AT (1) | ATE538782T1 (https=) |
| AU (1) | AU2003257473A1 (https=) |
| BR (1) | BR0312712A (https=) |
| CA (1) | CA2492378C (https=) |
| ES (1) | ES2379949T3 (https=) |
| PT (1) | PT1556027E (https=) |
| TW (1) | TW200403052A (https=) |
| WO (1) | WO2004006907A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1838968A (zh) | 2003-08-08 | 2006-09-27 | 艾伯吉尼斯公司 | 针对甲状旁腺激素(pth)之抗体和其用途 |
| US7318925B2 (en) | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
| EP3257949A1 (en) | 2005-06-15 | 2017-12-20 | Complete Genomics Inc. | Nucleic acid analysis by random mixtures of non-overlapping fragments |
| CN105641686A (zh) * | 2005-09-19 | 2016-06-08 | 爱密斯菲尔科技公司 | N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形 |
| BRPI0716261A2 (pt) * | 2006-08-31 | 2013-08-06 | Novartis Ag | composiÇÕes farmacÊuticas compreendendo hch para distribuiÇço oral |
| JP5577094B2 (ja) * | 2006-08-31 | 2014-08-20 | エミスフェアー・テクノロジーズ・インク | 活性薬剤を送達するための化合物及び組成物 |
| PL2215047T3 (pl) | 2007-11-02 | 2014-05-30 | Emisphere Tech Inc | Sposób leczenia niedoborów witaminy b12 |
| WO2011106378A2 (en) * | 2010-02-24 | 2011-09-01 | Emisphere Technologies, Inc. | Oral b12 therapy |
| RU2504536C1 (ru) * | 2012-08-20 | 2014-01-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Производное амида салициловой кислоты, обладающее антибактериальной, противогрибковой и антилизоцимной активностью |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260321A (en) * | 1984-11-12 | 1993-11-09 | Sandoz Ltd. | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins |
| US5733647A (en) * | 1992-11-05 | 1998-03-31 | Polymer Innovations, Inc. | Insole |
| US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
| US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| CN1151836C (zh) * | 1995-03-31 | 2004-06-02 | 艾米斯菲尔技术有限公司 | 用作传送活性剂的化合物和组合物 |
| ATE383169T1 (de) * | 1997-02-07 | 2008-01-15 | Emisphere Tech Inc | Komponente und zusammensetzungen zur verabreichung von wirkstoffen |
| US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| ES2235854T3 (es) * | 1999-04-05 | 2005-07-16 | Emisphere Technologies, Inc. | Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos. |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
-
2003
- 2003-07-15 TW TW092119264A patent/TW200403052A/zh unknown
- 2003-07-16 AT AT03763878T patent/ATE538782T1/de active
- 2003-07-16 CA CA2492378A patent/CA2492378C/en not_active Expired - Fee Related
- 2003-07-16 CN CN038169231A patent/CN1668290B/zh not_active Expired - Fee Related
- 2003-07-16 BR BR0312712-5A patent/BR0312712A/pt not_active IP Right Cessation
- 2003-07-16 WO PCT/EP2003/007739 patent/WO2004006907A1/en not_active Ceased
- 2003-07-16 PT PT03763878T patent/PT1556027E/pt unknown
- 2003-07-16 JP JP2004520655A patent/JP4541884B2/ja not_active Expired - Fee Related
- 2003-07-16 AU AU2003257473A patent/AU2003257473A1/en not_active Abandoned
- 2003-07-16 EP EP03763878A patent/EP1556027B1/en not_active Expired - Lifetime
- 2003-07-16 US US10/521,492 patent/US20060106110A1/en not_active Abandoned
- 2003-07-16 ES ES03763878T patent/ES2379949T3/es not_active Expired - Lifetime
-
2008
- 2008-07-08 US US12/169,184 patent/US20080280817A1/en not_active Abandoned
-
2011
- 2011-12-15 US US13/327,129 patent/US8664211B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| JP2005526147A5 (https=) | ||
| DE60143393D1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| NL300650I2 (nl) | Olodaterol, het R-enantiomeer daarvan, mengsels van isomeren daarvan, zuuradditiezouten met farmacologisch aanvaardbare zuren daarvan, evenals solvaten en/of hydraten daarvan, in het bijzonder Olodaterol en Olodaterolhydrochloride | |
| JP2004529078A5 (https=) | ||
| JP2004523498A5 (https=) | ||
| JP2004532810A5 (https=) | ||
| JP2004525194A5 (https=) | ||
| DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
| AU2002328343A1 (en) | Wax-based compositions and the use thereof as body care agents | |
| DE60117046D1 (de) | Kombination von fenofibrat und von coenzym q10 für die behandlung der endotheliaal missfunktion | |
| JP2005535670A5 (https=) | ||
| JP2003213455A5 (https=) | ||
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| USD530485S1 (en) | Crotches for shorts | |
| IL166257A (en) | 2-Amino Compounds Benzothiazole Sulfonamides, and Their Use in the Preparation of HIV Protease Inhibition Drugs | |
| JP2006199609A5 (https=) | ||
| JP2009019158A5 (https=) | ||
| JP2006527741A5 (https=) | ||
| RU2003120857A (ru) | Адаптогенное средство | |
| EP1411964A4 (en) | PEPTIDES MODULATING BLOOD COAGULATION AND METHODS OF USE | |
| RU99126233A (ru) | Антиаритмическое средство | |
| AR045724A1 (es) | Composicion farmaceutica orodispersable de un compuesto antitrombotico | |
| JPH10273446A5 (https=) |